Autologous CAR-T Cells Targeting B7-H3 in PDAC

Clinical trial NCT06158139 · RECRUITING

Trial details

NCT number: NCT06158139
Sponsor: UNC Lineberger Comprehensive Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreas Cancer Relapse Resistant Cancer

Start date: 2024-07-18
Primary completion: 2028-04-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.